Literature DB >> 8157366

Suppressive effect of recombinant human Cu, Zn-superoxide dismutase on lung metastasis of murine tumor cells.

N Yoshizaki1, Y Mogi, H Muramatsu, K Koike, K Kogawa, Y Niitsu.   

Abstract

The inhibitory effect of recombinant human Cu++Zn++superoxide dismutase (rhSOD) on metastasis of tumor cells in the mouse was investigated. In an experimental pulmonary metastasis model employing Meth A cells as inoculum, significant inhibition of metastasis was obtained by intravenous pre- and post-administration of rhSOD. An inhibitory effect of rhSOD was also observed in a spontaneous pulmonary metastasis model with 3LL cells as the inoculum. rhSOD was not observed to have any significant effects on the platelet-aggregating activity of tumor cells, the adhesiveness of tumor cells to vascular components (endothelial cells, laminin and type-IV collagen), or the growth of tumor cells either in vitro or in vivo. However, rhSOD suppressed invasion of Meth A and 3LL cells into Matrigel (an artificially reconstituted basement membrane of collagen, laminin and heparan sulfate) in the presence of hypoxanthine and xanthine oxidase, in vitro producers of superoxide. Thus, the present study shows that rhSOD is able to inhibit both experimental and spontaneous pulmonary metastasis, possibly through the suppression of tumor cell invasion into the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8157366     DOI: 10.1002/ijc.2910570226

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

Review 1.  On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies.

Authors:  Carolina Muscoli; Salvatore Cuzzocrea; Dennis P Riley; Jay L Zweier; Christoph Thiemermann; Zhi-Qiang Wang; Daniela Salvemini
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

2.  A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer.

Authors:  Jianqing Lin; Marianna Zahurak; Tomasz M Beer; Charles J Ryan; George Wilding; Paul Mathew; Michael Morris; Jennifer A Callahan; Gilad Gordon; Steven D Reich; Michael A Carducci; Emmanuel S Antonarakis
Journal:  Urol Oncol       Date:  2011-08-04       Impact factor: 3.498

3.  The role of nicotinamide adenine dinucleotide phosphate oxidase-derived reactive oxygen species in the acquisition of metastatic ability of tumor cells.

Authors:  Futoshi Okada; Masanobu Kobayashi; Hiroki Tanaka; Tokushige Kobayashi; Hiroshi Tazawa; Yoshihito Iuchi; Kunishige Onuma; Masuo Hosokawa; Mary C Dinauer; Nicholas H Hunt
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

4.  Enhanced inhibition of experimental metastasis by the combination chemotherapy of Cu-Zn SOD and adriamycin.

Authors:  K Kogawa; H Muramatsu; M Tanaka; Y Nishihori; S Hagiwara; K Kuribayashi; K Nakamura; K Koike; S Sakamaki; Y Niitsu
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

5.  Inhibition of experimental hepatic metastasis by targeted delivery of catalase in mice.

Authors:  Makiya Nishikawa; Ayumi Tamada; Kenji Hyoudou; Yukari Umeyama; Yuki Takahashi; Yuki Kobayashi; Hitomi Kumai; Emi Ishida; Frantisek Staud; Yoshiyuki Yabe; Yoshinobu Takakura; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

6.  Essential role of protein kinase C zeta in transducing a motility signal induced by superoxide and a chemotactic peptide, fMLP.

Authors:  Kageaki Kuribayashi; Kiminori Nakamura; Maki Tanaka; Tsutomu Sato; Junji Kato; Katsunori Sasaki; Rishu Takimoto; Katsuhisa Kogawa; Takeshi Terui; Tetsuji Takayama; Takayuki Onuma; Takuya Matsunaga; Yoshiro Niitsu
Journal:  J Cell Biol       Date:  2007-03-26       Impact factor: 10.539

7.  Prevention of inflammation-mediated acquisition of metastatic properties of benign mouse fibrosarcoma cells by administration of an orally available superoxide dismutase.

Authors:  F Okada; H Shionoya; M Kobayashi; T Kobayashi; H Tazawa; K Onuma; Y Iuchi; N Matsubara; T Ijichi; B Dugas; M Hosokawa
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

8.  Enhanced expression of type IV collagen-binding protein (p29) in Fyn-transfected murine fibrosarcoma cells.

Authors:  Kazuhiko Koike; Katsuhisa Kogawa; Tetsuji Takayama; Naohito Yoshizaki; Hirohito Muramatsu; Kiminori Nakamura; Sumio Sakamaki; Yoshiro Niitsu
Journal:  Jpn J Cancer Res       Date:  2002-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.